Improving Management of Patients at High Risk for Osteoporotic Fractures (0000-038)

Merck Sharp & Dohme (MSD)

Status: Completed

Conditions: Osteoporosis

Treatments: Behavioral: Disease Management Assessment

Study type: Interventional

Funder types: Industry

Identifiers

NCT00139438

0000-038

038

2005_049

Details and patient eligibility

About

The purpose of this study is to assess the impact of disease management interventions on percent receiving a bone densitometry test and percent appropriately prescribed a medication for osteoporosis.

Sex: All

Ages: 45+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Members of the Horizon Blue Cross Blue Shield of New Jersey who are at risk for osteoporosis based on age (women age 65 or older, men and women age 45 or older who have a history of fragility fracture or have a history of taking oral glucocorticoids over 3 months).

Exclusion criteria

• Individuals who are not members of Horizon Blue Cross Blue Shield of New Jersey and who otherwise do not meet the inclusion criteria.